JY Biomed and YC Biotech Announce IRB Submission for a Regenerative Medicine Clinical Study for Parkinson’s Disease
In April 2025, JY Biomed Inc. and YC Biotech Inc. jointly announced the submission of their collaborative regenerative medicine clinical study for Parkinson’s Disease (PD) to the Joint Institutional Review Board of Taipei Medical University and its affiliated hospitals. This study centers on the use of mesenchymal stem cells (MSCs) to evaluate their potential therapeutic […]










